Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
The Oncologist|July 18, 2023
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort StudyLorena Incorvaia, Dario De Biase, Margherita Nannini, et al.
Cancers|September 9, 2022
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with PazopanibSamuel Hidalgo-Ríos, Jaime Carrillo-García, David S Moura, et al.
Cancers|April 3, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma GroupEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Cancer Medicine|July 18, 2022
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 studyAnna Maria Frezza, Silvia Stacchiotti, Frederic Chibon, et al.
Journal of Clinical Medicine|April 3, 2021
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched DonorsFabrizio Carnevale-Schianca, Daniela Caravelli, Susanna Gallo, et al.
Cancers|July 2, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint StudyMassimo E Abate, Silvia Cammelli, Letizia Ronchi, et al.
Frontiers in Oncology|December 26, 2022
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a <i>post-hoc</i> analysisEmanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani, et al.
Ebiomedicine|July 17, 2024
Spatial distribution of tumour immune infiltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapySandro Pasquali, Viviana Vallacchi, Luca Lalli, et al.
Cancer|November 18, 2020
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupWilliam W Tseng, Francesco Barretta, Lorenzo Conti, et al.
The Lancet. Oncology|February 19, 2020
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trialJavier Martin-Broto, Josefina Cruz, Nicolas Penel, et al.
Pageof 15